LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study Federico Piñero; Marcos A. Thompson; Federico Diaz Telli; Juan Trentacoste; Carlos Padín; Manuel Mendizabal; Carla Colaci; Ariel Gonzalez Campaña; Josefina Pages; Silvina Montal; Mariano Barreiro; Martín Fauda; Gustavo Podestá; Juan Pablo Perotti; Marcelo Silva;

P-32 ACCESSIBILITY TO SEQUENTIAL SYSTEMIC TREATMENT AFTER TACE: IMPACT ON SURVIVAL IN A LATIN AMERICAN PROSPECTIVE COHORT FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Diego Arufe; Adriana Varón; Ana Palazzo; Jorge Rodríguez; Oscar Beltrán; Patricio Palavecino Rubilar; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Norberto Tamagnone; Hugo Cheinquer; Nicolás Cortés Medina; Juan Ignacio Marín; Estela Manero; Federico Orozco Ganem; Jaime Poniachik; Sebastián Marciano; Virginia Reggiardo; Manuel Mendizabal;

P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMAB PLUS BEVACIZUMAB IS ASSOCIATED WITH DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS FEDERICO PIÑERO; Margarita Anders; Carla Bermúdez; Ezequiel Demirdjian; Adriana Varón; Daniela Perez; Jorge Rodriguez; Oscar Beltrán; Javier Delgado García; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Alexandre Araujo; Juan Diego Torres Florez; Juan Ignacio Marín; Marina Villa; Federico Orozco Ganem; Jaime Poniachik; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;